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Comment on 'Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes' by S Tauro et al Leukemia (2002) The bone marrow stroma is known to play an integral role in the development and maintenance of normal hematopoiesis. Imperatively, stromal abnormalities have been suspected to contribute to the pathobiology of bone marrow disorders with impaired hematopoiesis. Particularly, in myelodysplastic syndromes (MDS) the postulate of abnormal stroma has existed for over a decade. The difficulties in establishing stromal layers from bone marrow aspirate mononuclear cells (BMMNC) of MDS patients acknowledged by many workers in the field have restricted investigations on the role of stroma in MDS to a handful studies. [1] [2] [3] [4] It appears that the ability to form stromal layers in vitro may vary from patient to patient, 3, 5 with a sizeable number of patients retaining the ability to form normal grade stroma. 1 Albeit inconsistent in type, most MDS stromal layers in vitro may demonstrate some hitherto incompletely characterized phenotypic and/or metabolic defects. 2, 3, 6 Interestingly, in previous studies the cytokine profile elaborated by the MDS stroma established from BMMNC, however, appeared hardly any different from that of the normal control cultures. [7] [8] [9] In line with these observations the hematopoietic growth supporting activity of the bone marrow stroma may be affected only in a subset of MDS patients. 2, 6, 9, 10 The report by Tauro et al in the present issue of Leukemia, 11 in an in vitro co-culture system, has investigated the effects of MDS stroma on an early hematopoietic F36P cell line that was originally established from MDS (RAEBt)→ leukemia patient.
12 These cells are dependent on granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin 3 (IL-3) for their growth and survival. As a result, in Tauro et al's study in the absence of GM-CSF or IL-3 in the negative controls, a significant number of these cells underwent apoptosis. On the other hand, in positive controls the presence of GM-CSF prevented apoptosis. Interestingly, both normal and MDS stroma seemed to compensate in part for the growth factor requirement of these cells, as the degree of apoptosis was reduced first to ෂ60% in transwell non-contact cultures and further to 35% in contact cultures as compared to the negative controls. According to the earlier cytokine investigations in the bone marrow stromal cultures in vitro, GM-CSF is detectable in the supernatant, but IL-3 seems to be produced in low amounts and not to diffuse well, hence requiring short-range interaction for its activity on the overlaying cells. 8, 9, 13 Since both normal and MDS stroma seem to be capable of producing GM-CSF and IL-3 in vitro, 9 owing to their activity ranges, in Tauro et al's study the compensatory effect of stroma was more prominent in direct contact co-cultures as compared to the non-contact transwell co-cultures. Interestingly, these differences in contact and non-contact co-cultures apparent in the case of growth factor-dependent F36P cells, were not evident when normal BMMNC were co-cultured with MDS stroma in the study by Deeg et al. 10 Tauro et al did not find appreciable levels of tumor necrosis factor ␣ in the supernatant nor see an increase in Fas expression in the overlaying F36P cells. Plausibly, therefore, the continued apoptosis of F36P cells in co-cultures may be the result of inadequate compensation of the growth factor requirement of these cells by the stroma rather than an active induction of apoptosis by stroma.
Further, in the study by the ratio of adherent F36P cells to the number of stromal cells in contact cultures appeared to be comparable in the case of normal as well as MDS stroma. In both, over a 72 h incubation period this ratio increased only marginally. Although the authors view this increase in the ratio as resulting from proliferation, more direct and specific methods measuring proliferation-related parameters may be needed to ascertain this proposition. In any case, the report by Tauro et al suggests that MDS stroma may retain normal growth-and survival-supporting activity. The title of their study then appears somewhat incoherent with their data. The fact that apoptosis, although less than the negative control (39.4%; absence of growth factor or stroma), was still detectable in the stromal co-cultures and that it was slightly higher in MDS as compared to normal cultures (15.7% vs 12.4% in contact and 26.3% vs 23.8% in non-contact), seems to have introduced a bias overshadowing the interpretation of the data presented by Tauro et al. Imperatively, the conclusion derived by the authors is that the MDS stroma supports survival but may induce apoptosis too and hence may functionally be altered. In fact, their findings as well as those of Deeg et al, 10 indicate that the MDS stroma may not have direct inhibitory effects on hematopoiesis.
It thus appears that the role of stroma in the pathobiology of MDS may continue to be enigmatic until we overcome the hurdles in establishing stromal cultures in vitro and assess their functional attributes with precisely specific state-of-the-art assays. Obviously then, only with a further technical refinement will we have a meaningful insight into the role of bone marrow stroma in MDS and hematopoiesis in general. We agree with Dr Mundle that the precise role of the stroma in the pathophysiology of myelodysplasia remains uncertain. However, we think that our data on the effect of normal and MDS stroma on model haemopoietic stem/progenitor cells (HPC), although open to different interpretations, show more than 'marginal' effects. We have used a model that can demonstrate interactions between stromal cells and haemopoietic cells over a relatively short time, unlike previous studies using more prolonged 2-stage Dexter co-cultures, [1] [2] [3] where precise effects on proliferation and survival are difficult to separate. Our central finding is that after 72 h co-culture, F-36P cell numbers increase by a similar amount (approximately 60%) with normal and MDS stromal layers, whereas standardized apoptotic ratios were significantly increased on MDS compared with normal stroma (mean 1.4 ± 0.5). This leads us to suggest that while the ability of MDS stroma to support HPC proliferation appears intact, stromal regulation of HPC survival may be deficient in MDS. Indeed, given the similar increases in F-36P numbers at 72 h, one could argue that the proliferative drive on MDS stroma may be greater than on normal stroma: increased apoptosis on MDS adherent layers might be accompanied by a compensatory increase in the proliferation of sub-populations of F-36P cells that are resistant to the 'apoptotic stimuli'.
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Due to limitations of cell numbers, our co-cultures were analysed at only two time-points (4 h and 72 h), and thus our data do not take into account possible changes in kinetics of F-36P cells (including exchange between the non-adherent and adherent compartments) between 4 and 72 h. We therefore agree that it remains to be determined whether the apparent stromal defect in MDS results from a decrease in stromal proliferative stimuli with time, eg reduced GM-CSF/IL-3 levels at 72 h in MDS stromal co-cultures, or from an excess of pro-apoptotic signals despite optimal levels of growth factors within the in vitro stromal microenvironment. The first hypothesis might be explored in dye-tracking experiments comparing proliferation of F-36P cells in the presence of rh-GM-CSF/IL-3, and in contact cultures with stroma. The latter hypothesis is at least plausible given the recent studies of the IL-3-dependent cell line TF-1 on LS801, an SV-40 transformed MDS stromal cell line: 4 in these co-cultures, death of TF-1 cells by apoptosis was observed despite optimal levels of IL-3 within cultures, suggesting the presence of mechanisms that can override pro-survival signals and induce cell death. A role for TNF-␣ in the pathogenesis of MDS has previously been suggested, 5 and despite the lack of diffusible TNF-␣ in F-36P MDS stromal co-cultures in our studies, a role for this cytokine in inducing apoptosis in F-36P cells cannot be excluded without quantifying levels within the adherent layers. Furthermore, it remains possible that stromal induction of apoptosis in MDS might be mediated by alternative, or hitherto unidentified cytokines.
Although our data do not identify the precise nature of the stromal 'defect' in MDS, they have generated a number of hypotheses that can be assessed further using the model of haemopoiesis we have described.
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